Literature DB >> 12438910

National laboratory reports of Chlamydia trachomatis seriously underestimate the frequency of genital chlamydial infections among women in Switzerland.

W John Paget1, Reinhard Zbinden, Eva Ritzler, Marcel Zwahlen, Christian Lengeler, Dieter Stürchler, Hans C Matter.   

Abstract

BACKGROUND: Public health authorities want to evaluate their sexually transmitted disease (STD) surveillance systems to promote the most effective use of health resources. GOAL: The goal of this study was to estimate the sensitivity of national laboratory reports of in Switzerland (the proportion of cases detected by national laboratory reports). STUDY
DESIGN: A cross sectional prevalence study was conducted by the Swiss Sentinel Surveillance Network of Gynecologists in 1998. Two groups of women aged less than 35 years were included in the study: those having a first consultation for pregnancy and those having a routine check-up.
RESULTS: A total of 1589 women were tested for. The prevalence among pregnant women (n = 817) was 1.3%, and that among sexually active women (n = 772) was 2.8%. Using the prevalences observed among check-up women, we estimate that there were at least 24,400 infections in Switzerland among women aged 20 to 34 years in 1998 (95% CI: 14,300-34,300). The number of laboratory reports of in this age group was 1,150 in 1998.
CONCLUSION: Our study suggests that the sensitivity of national laboratory reports of in 1998 was less than 5% for women aged 20 to 34 years.

Entities:  

Mesh:

Year:  2002        PMID: 12438910     DOI: 10.1097/00007435-200211000-00016

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

1.  Prevalence and associated factors for Chlamydia trachomatis infection among undocumented immigrants in a primary care facility in Geneva, Switzerland: a cross-sectional study.

Authors:  Yves Jackson; Paul Sebo; Gaelle Aeby; Patrick Bovier; Beatrice Ninet; Jacques Schrenzel; Philippe Sudre; Dagmar Haller; Jean-Michel Gaspoz; Hans Wolff
Journal:  J Immigr Minor Health       Date:  2010-12

2.  Diagnostic relevance of simultaneous testing for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  B Sakem; R Michel; U E Nydegger; D Radjenovic; M Wydler; M Risch; L Risch
Journal:  Infection       Date:  2011-04-27       Impact factor: 3.553

3.  Chlamydia trachomatis prevalence, genotype distribution and identification of the new Swedish variant in Southern Germany.

Authors:  N Fieser; U Simnacher; Y Tausch; S Werner-Belak; S Ladenburger-Strauss; H von Baum; U Reischl; A Essig
Journal:  Infection       Date:  2012-08-02       Impact factor: 3.553

4.  Low prevalence of Chlamydia trachomatis infection in asymptomatic young Swiss men.

Authors:  David Baud; Katia Jaton; Claire Bertelli; Jean-Pierre Kulling; Gilbert Greub
Journal:  BMC Infect Dis       Date:  2008-04-12       Impact factor: 3.090

Review 5.  Knowing the unknown: The underestimation of monkeypox cases. Insights and implications from an integrative review of the literature.

Authors:  Nicola Luigi Bragazzi; Woldegebriel Assefa Woldegerima; Sarafa Adewale Iyaniwura; Qing Han; Xiaoying Wang; Aminath Shausan; Kingsley Badu; Patrick Okwen; Cheryl Prescod; Michelle Westin; Andrew Omame; Manlio Converti; Bruce Mellado; Jianhong Wu; Jude Dzevela Kong
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

6.  Chlamydia trachomatis prevalence in undocumented migrants undergoing voluntary termination of pregnancy: a prospective cohort study.

Authors:  Hans Wolff; Ana Lourenço; Patrick Bodenmann; Manuella Epiney; Monique Uny; Nicole Andreoli; Olivier Irion; Jean-Michel Gaspoz; Jean-Bernard Dubuisson
Journal:  BMC Public Health       Date:  2008-11-24       Impact factor: 3.295

7.  Testing for Chlamydia trachomatis: time trends in positivity rates in the canton of Basel-Stadt, Switzerland.

Authors:  C Schmutz; D Burki; R Frei; M Mäusezahl-Feuz; D Mäusezahl
Journal:  Epidemiol Infect       Date:  2012-11-19       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.